Member Info for 2Phones

How can any one disagree with such a cogent arguement - and clearly not the rantings of a one track numpty.

I don't agree - the operational update earlier this year had a predicted cash runway to H2 next year - when you couple that with the recruitment of 2 sales people and a director of clinical partnerships, I would anticipate growth in cash inflow. However, they are a small team and they are going to have to increase production to accommodate the anticipated sales. This will need funding, but where they get it is uncertain – one option being a placing.

I think that many of us are here is because of the impetus due to Russia’s invasion and its impact on Military spending and innovation. In February the biggest sustained increase in defence spending since the Cold War was announced. I’m pretty sure if the situation becomes more urgent this will increase further.

And when he joined 25 Sept 24 the share price was 11.92 and today it is 9.7 - how's that working for you? Is he just averaging down?

And he is constrained from buying as it would be insider trading - if there is significant SP impacting news. Which we mostly believe that is likely.

Donmac agreed - two of the latest RNS are very positive about the rate of revenue growth and market penetration - can't help but think the next sales based RNS will be a gamechanger.

Interesting news today – initially I thought why? This has little bearing on shareholders interests – however, on further concideration, while successful audits add little to the bottom line or turnover or even shareholder value – in our case it is very much a Critical Failure Factor, where failure to pass a quality audit could seriously damage the company in the short/medium term. Also it does point to a well run, disciplined business. So well done Verici.

Couple of big trades after close - they look like sells.... Shorts closing??

I wonder if the last two days rapid rise is due to the video of the Iron robot - it looks vastly superior to the Tesla Optimus. Time will tell but this has every chance of stealing Musk's thunder.

I guess this is what comprises Sara Barrington’s addressable market of $900m in the Half year report RNS on September 30.

Another way to look at the size of the opportunity in the US alone, is the number of Kidney transplants per year. This stood at 27332 in 2023, and there were 90323 people on waiting lists in 2024. If we get to enough of the providers and they use multiple tests per transplant the size of this will be huge.

Dtlp - Thanks for the guide. Have you read section 12 Warrant instuments section c (page 62) - warrant instrument dated 28 July 2025 in respect of up to 389,305,000 Ordinary Shares. Does this mean there is likely more in the wings?

What is oilies agenda – there are no apparent shorters here (probably) – so not likely to be on the payroll. Does he not get what the rest of us have grasped – AI has very much arrived and importantly it is predicted to be critical in the field of defence. That coupled with huge US investments in the UK AI industry represents a massive opportunity for a company that is apparently ahead of the curve for UK sovereign AI tech. We all know it’s a punt – but that is AIM. However, it is a pretty good punt given the current headwinds. Revenue and profits are not the concern of investors here – we are banking on these coming in abundance much further down the road.

On Australia, I have been following the progress of a company called Polarblue down there who seem to be making very bullish boasts about their tech and are attracting investment from this country.

You are right Yoda - there has been a 25% rise while I have been waiting - I am in the process of opening a Lloyds account. Hopefully that will be better

I have had an order on 212 for over 24 hours and no sign of a purchase - anyone else?

So it's not London School of Economics then?

Fair enough - filtered

Desperate wee tiddler - just basing the statement on official company releases not on your very humble opinion. You are still stating that there is a monthly burn - without any evidence. And it is thanks to additional contractual obligations - you know those hand-shakes that aren't FIDs

ITM Power is delighted to announce two positive changes to its FY25 guidance:

Revenue is now expected to be between £25.5m and £26.5m, a 30% increase compared to the midpoint of the previously announced range of £18m to £22m. This increase is due to additional contractual obligations (not hand shakes) having been fulfilled and associated revenue now recognised.

In addition, ITM has been net cash generative in the second half of FY25, and we now expect cash at the end of the financial year to be between £204m and £205m, an increase compared to our half-year cash balance, which stood at £203m.